P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

NCT06014762 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
High-grade B-cell Lymphoma
Primary Mediastinal Large B-cell Lymphoma (PMBCL)
Transformed Follicular Lymphoma (tFL)
Follicular Lymphoma Grade 3B
DLBCL
DLBCL - Diffuse Large B Cell Lymphoma
DLBCL Arising From Follicular Lymphoma
DLBCL, Diffused Large B Cell Lymphoma
DLBCL NOS

Interventions

BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid

Sponsor

Poseida Therapeutics, Inc.

Collaborators

[object Object]